Seelos Therapeutics logo
Seelos Therapeutics SEEL
$ 1.28 -47.76%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Seelos Therapeutics EBITDA per Share 2011-2024 | SEEL

Annual EBITDA per Share Seelos Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-8.26 -20 -0.679 -0.398 -1.44 -12 -26.6 -60.3 -126 -183 -163 -94.4 -263

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.398 -263 -73.9

Quarterly EBITDA per Share Seelos Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - -0.16 -0.2 -0.13 - -0.11 -0.08 -0.24 - -0.09 -0.08 -0.16 - -0.15 -0.16 -1.38 - -0.35 -0.14 -0.2 - -0.27 -0.21 -0.23 - -0.23 -0.72 -0.86 - -1.12 -0.11 -0.13 - -0.08 0.03 -0.09 - -0.08 -0.12 -0.2 - -0.06 -0.16 -0.15 - -0.09 -0.37 -0.15

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
0.03 -1.38 -0.251